Encompass Health Corp at Barclays Global Healthcare Conference Transcript
All right. Great. Welcome to Day 2 of the Barclays Healthcare Conference. I'm Steven Valiquette, the healthcare services analyst. Going to kick things off with Encompass this morning for this session, we have Mark Tarr, the company's CEO; and also Doug Coltharp, the CFO of the company. And we have Mark Miller from Investor Relations in the audience here as well. This will be a fireside chat. So I guess we'll just dive right in.
Perfect.
Questions & Answers
All right. Great. So maybe to start with kind of talking about some of the key growth drivers for the company. I think for '22 to '26, you guys talked about 6 to 10 de novo openings per year. On top of that, adding now 80 to 120 net additions per year to existing facilities and having all that culminate in a 6% to 8% discharge CAGR.
So I guess when thinking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |